Erlotero 150 Erlotero 150 contains Erlotinib 150 mg, a targeted anti-cancer medicine designed for the treatment of cancers that carry specific EGFR gene mutations. It works by blocking signals that encourage cancer cells to grow and spread, helping to slow disease progression. This medicine is commonly prescribed for certain types of lung cancer and is used only under the supervision of an oncologist as part of a personalized treatment plan.